Tvardi Therapeutics
About Tvardi Therapeutics
Tvardi is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. STAT3 is a central mediator across critical fibrotic signaling pathways that drive uncontrolled deposition, proliferation, survival and immune suppression. STAT3 is also positioned at the intersection of many signaling pathways integral to the survival and immune evasion of cancer cells. The company is conducting Phase 2 clinical trials in fibrosis-driven diseases with high unmet need: idiopathic pulmonary fibrosis (NCT05671835) and hepatocellular carcinoma (NCT05440708).
Find Tvardi Therapeutics Execs' Valid Emails
Up to 90% verified emails and mobile numbers, refreshed weekly.
Company Details
1M-5M
Biotechnology Research
2-10 employees
Public Company
Houston, TX
United States
Frequently Asked Questions about
What is Tvardi Therapeutics's industry?
Tvardi Therapeutics operates in the Biotechnology Research industry and is headquartered in United States.
How many employees does Tvardi Therapeutics have?
Tvardi Therapeutics has approximately 2-10 employees employees.
Where is Tvardi Therapeutics's based?
Tvardi Therapeutics is based in Houston, TX, United States.
Is Tvardi Therapeutics publicly listed?
Yes. Tvardi Therapeutics is a publicly traded company.
How can I contact Tvardi Therapeutics's investor relations team?
You can reach Tvardi Therapeutics’s investor relations department through the contact section on their official website or directly via the investor relations email listed in their latest SEC filings.
Find verified emails and phone numbers for professionals like those at
Up to 90% verified emails and mobile numbers, backed by weekly job-change alerts.
Find verified emails at this company
An email pattern tells you the format. It does not tell you who works there now or whether an address still delivers. Scalelist returns verified contacts, checked at the point you build the list.